FDA Approved: LAMICTAL ODT — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

The FDA approved a new orally disintegrating tablet formulation of lamotrigine (Lamictal ODT). It was approved under GlaxoSmithKline's original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• LAMICTAL ODT (lamotrigine)

Snippet

ORIG AP for LAMICTAL ODT (LAMOTRIGINE)